Securing Optimal Product Formulary Coverage to Ensure Uninterrupted Patient Access with a Thorough Comprehension of Current Drug Review Considerations, Impact of Prescribing Practices on Provider Considerations and Exploring the Effect of Potential Rebated Changes on the Market
There has been considerable attention over the last year regarding the current landscape regarding drug coverage, pricing and overall patient access and the current administration’s focus in recent months has been on changing the current process surrounding drug product rebates. With continued changes being proposed, executives responsible for managed market account management are facing an uncertain future for the coverage and reimbursement of vital health products and are tasked with ensuring continued funding for life-altering treatments from both public and private payers. Managed care executives from the manufacturing, payer, PBM and IDN organizations will offer great insight to healthcare delivery trends’ and patient adherence impact on overall drug spending, the potential changes brought about by the proposed elimination of rebates, and uninterrupted patient access for products on exclusion lists. Interactive discussions will enable all stakeholders from the pharmaceutical and payer communities as well as pharmacy benefit managers the opportunity for open debate and discussion to ensure mutually beneficial relationships between patients and caregivers.